WMSA
CORV

Weiss Multi-Strategy Advisers’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,000
Closed -$20K – 1039
2013
Q2 		$20K Buy
+10,000
New +$20.1K ﹤0.01% 738

Other funds holding CORV

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CORV Position: Q3 2013 in Review

Weiss Multi-Strategy Advisers sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2013, closing a stake of 10,000 shares — an estimated $20K sold.

Weiss Multi-Strategy Advisers first reported a position in CORV in Q2 2013 and held it in 1 quarter. The position peaked at $20K in Q2 2013. 19 funds tracked by Wall St. Rank hold CORV as of Q3 2013.

  • Weiss Multi-Strategy Advisers reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2013 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2013, an estimated $20K.
  • Weiss Multi-Strategy Advisers first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $20K in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2013.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2013, filed 14 Nov 2013.